Literature DB >> 20601885

Hypercalcemia in children and adolescents.

Steven A Lietman1, Emily L Germain-Lee, Michael A Levine.   

Abstract

PURPOSE OF REVIEW: In this review, we define hypercalcemia levels, common causes for hypercalcemia in children, and treatment in order to aid the practicing pediatrician. RECENT
FINDINGS: One rare cause of hypercalcemia in the child is familial hypocalciuric hypercalcemia (also termed familial benign hypercalcemia). Mutations that inactivate the Ca-sensing receptor gene FHH have been described as an autosomal dominant disorder, but recently milder mutations in the CASR have been shown to cause hypercalcemia when homozygous.
SUMMARY: Normal serum levels of calcium are maintained through the interplay of parathyroid, renal, and skeletal factors. In this review, we have distinguished the neonate and infant from the older child and adolescent because the causes and clinical features of hypercalcemia can differ in these two age groups. However, the initial approach to the medical treatment of severe or symptomatic hypercalcemia is to increase the urinary excretion of calcium in both groups. In most cases, hypercalcemia is due to osteoclastic bone resorption, and agents that inhibit or destroy osteoclasts are, therefore, effective treatments. Parathyroid surgery, the conventional treatment for adults with symptomatic primary hyperparathyroidism, is recommended for all children with primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601885      PMCID: PMC2967024          DOI: 10.1097/MOP.0b013e32833b7c23

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  65 in total

1.  New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia.

Authors:  Mika Tadokoro; Rie Kanai; Takeshi Taketani; Yuji Uchio; Seiji Yamaguchi; Hajime Ohgushi
Journal:  J Pediatr       Date:  2009-06       Impact factor: 4.406

2.  A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.

Authors:  Steven A Lietman; Yardena Tenenbaum-Rakover; Tjin Shing Jap; Wu Yi-Chi; Yang De-Ming; Changlin Ding; Najat Kussiny; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

Review 3.  Familial parathyroid tumors: diagnosis and management.

Authors:  Peter Stålberg; Tobias Carling
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

4.  Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.

Authors:  Ramona Rus; Christine Haag; Christiane Bumke-Vogt; Volker Bähr; Bernhard Mayr; Matthias Möhlig; Egbert Schulze; Karin Frank-Raue; Friedhelm Raue; Christof Schöfl
Journal:  J Clin Endocrinol Metab       Date:  2008-09-16       Impact factor: 5.958

5.  Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor.

Authors:  Jenny Ying Lin Lu; Yuhua Yang; Gilles Gnacadja; Arthur Christopoulos; Jeff D Reagan
Journal:  J Pharmacol Exp Ther       Date:  2009-09-16       Impact factor: 4.030

6.  Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Konstantinos Vahtsevanos; Athanassios Kyrgidis; Evgenia Verrou; Eirini Katodritou; Stefanos Triaridis; Charalampos G Andreadis; Ioannis Boukovinas; Georgios E Koloutsos; Zisis Teleioudis; Kyriaki Kitikidou; Panagiotis Paraskevopoulos; Konstantinos Zervas; Konstantinos Antoniades
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

Review 7.  Aquaporin-2 abundance in the renal collecting duct: new insights from cultured cell models.

Authors:  Udo Hasler; Valérie Leroy; Pierre-Yves Martin; Eric Féraille
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

8.  Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene.

Authors:  Barbora Obermannova; Karolina Banghova; Zdenek Sumník; Hana M Dvorakova; Jan Betka; Filip Fencl; Stanislava Kolouskova; Ondrej Cinek; Jan Lebl
Journal:  Eur J Pediatr       Date:  2008-08-27       Impact factor: 3.183

9.  Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress.

Authors:  N Demirel; M Aydin; A Zenciroglu; N Okumus; S Cetinkaya; Y T Yildiz; M S Ipek
Journal:  Ann Trop Paediatr       Date:  2009-06

10.  Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.

Authors:  S E Lloyd; A A Pannett; P H Dixon; M P Whyte; R V Thakker
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more
  29 in total

1.  An infant with hypercalcemia: answers.

Authors:  Stefano Guarino; Pierluigi Marzuillo; Andrea Apicella; Luigi Annicchiarico Petruzzelli; Angela La Manna
Journal:  Pediatr Nephrol       Date:  2013-10-19       Impact factor: 3.714

Review 2.  Green Urine in Traditional Persian Medicine: Differential Diagnosis and Clinical Relevance.

Authors:  Sepideh Kolouri; Babak Daneshfard; Amir-Mohammad Jaladat; Vahid Tafazoli
Journal:  J Evid Based Complementary Altern Med       Date:  2016-07-08

3.  A child presenting with hypercalcemia.

Authors:  Emre Çelik; Gül Nihal Özdemir; Gülen Tüysüz; Yücel Taştan; Halit Çam; Tiraje Celkan
Journal:  Turk Pediatri Ars       Date:  2014-03-01

4.  Vitamin D toxicity in an infant: case files of the University of California, San Francisco medical toxicology fellowship.

Authors:  Craig Smollin; Warittha Srisansanee
Journal:  J Med Toxicol       Date:  2014-06

5.  A toddler with severe hypercalcemia and pyelonephritis: Answers.

Authors:  Joseph Wilbanks; Jessica Hillyer; Faris Hashim; David Sas; Christian Hanna
Journal:  Pediatr Nephrol       Date:  2020-07-20       Impact factor: 3.714

Review 6.  Hypercalcemia: a consultant's approach.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.714

7.  Parathyroid Hormone-Related Peptide (PTHrP): Evaluation of Pediatric, Covariate-Stratified Reference Intervals.

Authors:  Vincenzo Brescia; Antonietta Fontana; Roberto Lovero; Carmela Capobianco; Stella Vita Marsico; Tiziana De Chirico; Carla Pinto; Elisa Mascolo; Angela Pia Cazzolla; Maria Felicia Faienza; Francesca Di Serio
Journal:  Children (Basel)       Date:  2022-06-15

8.  Inherited disorders of calcium and phosphate metabolism.

Authors:  Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

9.  Hypercalcemia in Patients with Williams-Beuren Syndrome.

Authors:  Sampat Sindhar; Michael Lugo; Mark D Levin; Joshua R Danback; Benjamin D Brink; Eric Yu; Dennis J Dietzen; Amy L Clark; Carolyn A Purgert; Jessica L Waxler; Robert W Elder; Barbara R Pober; Beth A Kozel
Journal:  J Pediatr       Date:  2016-08-26       Impact factor: 4.406

10.  Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients.

Authors:  Yuan Du; Vincent Blay Roger; Jorge Mena; Misun Kang; Marshall L Stoller; Sunita P Ho
Journal:  J Pediatr Urol       Date:  2020-11-20       Impact factor: 1.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.